BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Nona Biosciences Expands Integrated Framework To Support Early Clinical Development And IITs

Nona Biosciences, a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, announced the expansion o...

January 02, 2026 | News

Enveda Advances Third Asset Into The Clinic As FDA Clears IND For ENV 6946 In Inflammatory Bowel Disease

Enveda achieves a significant milestone with three assets now in clinical development, further validating its platform’s ability to deliver differe...

December 25, 2025 | News

Jacobio Pharma Strikes Global Deal With AstraZeneca For Pan KRAS Inhibitor JAB 23E73

Jacobio Pharma announced that it has entered an agreement with AstraZeneca for its proprietary Pan-KRAS inhibitor JAB-23E73. AstraZeneca will receive ...

December 23, 2025 | News

PeptiDream Advances Oral Dual IL17 Inhibitor Into Clinical Development Portfolio

PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company (President: Patrick C. Reid, hereinafter “PeptiDream”)(Tokyo: 4587) a...

December 19, 2025 | News

APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage

APAC Biopharma in Review: What Truly Moved the Needle This Year Asia-Pacific (APAC) has cemented its status as a pivotal biopharmaceutical hub in 2025, ma...

December 15, 2025 | Report

Zealand Pharma And OTR Therapeutics Forge Strategic Collaboration To Advance Next Generation Metabolic Therapies

Collaboration will combine Zealand Pharma's expertise in obesity and metabolic health with OTR Therapeutics' proprietary oral small-molecule platform and...

December 12, 2025 | News

Hiropharmaconsulting Secures Japan Patent For First AI Enabled Pharmacovigilance Validation Method

HiroPharmaConsulting (R) Co., Ltd. announced that it has received a patent for an innovative Good Pharmacovigilance Practice (GVP) Computerized System Vali...

December 05, 2025 | News

GC Biopharma Achieves WHO Recognition for MAV Zero Six Varicella Vaccine Strain

Officially recognized by WHO as a standard varicella vaccine strain alongside Oka Interchangeability endorsed, enhancing global supply securit...

December 03, 2025 | News

Piramal Pharma Solutions Achieves Full Compliance With Global Nitrosamine Standards

Piramal Pharma Solutions implemented a robust action plan to address evolving regulatory requirements pertaining to nitrosamine impur...

November 28, 2025 | News

eXmoor Pharma and Royal Free London’s CVIC Form Strategic Partnership to Streamline UK Cell and Gene Therapy Manufacturing

eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, and Royal Free London NHS Foundation Trust, throug...

November 27, 2025 | News

ACG Introduces DryPod The New Lamination Based Desiccant Cold Form Solution That Gives Drug Makers Full Control Over Moisture Protection

ACG, the world’s most integrated provider of solid-dosage and packaging solutions, announced the launch of DryPod™, a next-generatio...

November 24, 2025 | News

Evonik and InVitria Partner to Expand Global Supply of Animal Component-Free Recombinant HSA

Expanded supply of animal component-free human serum albumin for advanced therapies and next-generation biopharmaceutical processes Safer, more consiste...

November 18, 2025 | News

Lupin Launches Risperidone Long Acting Injectable in the United States with PrecisionSphere Technology

Global pharma major Lupin announced the launch of Risperidone for extended-release injectable suspension, 25 mg per vial, 37.5 mg per vial, and 5...

November 17, 2025 | News

Vaxcellbio and Seoul National University Partner To Develop Next Generation DDS Formulation for Macular Degeneration Therapies

Vaxcellbio (CEO Je-Jung Lee, MD, PhD ), a leading immuno-oncology company, announced that it has entered into a strategic memorandum of underst...

November 13, 2025 | News

Stay Connected